Effect of Naproxen,a Prostaglandin Inhibitor,on Acute Otitis Media and Persistence of Middle Ear Effusion in Children

Abstract

Prostaglandins are thought to be of importance in the pathophysiology of otitis media with effusion (OME), and the possibility of reducing the frequency and persistence of this condition by using prostaglandin inhibitors has been suggested. In a double blind manner, naproxen was administered to children with acute otitis media, in addition to amoxicillin, and its influence on the subsequent occurrence and persistence of middle ear effusion was evaluated. Eighty-one children participated in the study. No significant difference was found in the number of patients with tympanograms consistent with OME in the two groups. After 10 days of treatment, 63% in the naproxen and 58% in the placebo group, and after 30 days, 41% and 59%, respectively, had type B tympanograms. Similarly, there were no differences between the two groups with respect to other parameters studied (duration of otalgia, fever, otoscopic findings). No side effects related to naproxen were observed.

Keywords

acute otitis media naproxen otitis media with effusion prostaglandins

Get full access to this article

View all access options for this article.

References

Teele

Klein

Rosner

. Epidemiology of otitis media in children. Ann Otol Rhinol Laryngol 1980; 89(suppl 68): 5–6.

Shurin

Pelton

Donner

Klein

. Persistency of middle ear effusion after acute otitis media in children. N Engl J Med 1979; 300: 1121–3.

Schwartz

Rodriquez

Grundfast

. Pharmacological compliance with antibiotic therapy for acute otitis media: Influence on subsequent middle ear effusion. Pediatrics 1981; 68: 619–22.

Olmsted

Alvarez

Moroney

Eversden

. The pattern of hearing following acute otitis media. J Pediatr 1964; 65: 252–5.

Fraser

Mehta

Fraser

. The medical treatment of secretory otitis media. A clinical trial of three commonly used regimens. J Laryngol Otol 1977; 91: 757–65.

Formigoni

Coifman

Salzberg

. Naproxen sodium in the treatment of the acute pharyngotonsillitis. Rev Bras Med 1980; 37: 332–8.

Andrew

. Clinical interest in the use of antibiotics with an anti-inflammatory. Rev Med 1972; 25: 93.

Luporini

Abbas

De Silva

. Naproxen sodium plus ampicillin in the treatment of acute respiratory infections. Curr Ther Res 1981; 30: 540–8.

Orozca

Roc

. Naproxen sodium in the treatment of otitis media. Invest Med Int 1978; 5: 304–10.

10.

Brogden

Heel

Speight

Avery

. Naproxen up to date: A review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states. Drugs 1979; 18: 241–328.

11.

Makela

. Naproxen in the treatment of juvenile rheumatoid arthritis. Scand J Rheumatol 1977; 6: 193–205.

12.

Rooks

Ruuth

. Sodium naproxen, a potent anti-exudative agent in a model employing pleural effusion. Invest Med Int 1975; 2: 246–8.

13.

Bernstein

Okazaki

Reisman

. Prostaglandins in middle ear effusions. Arch Otolaryngol 1976; 102: 257–8.

14.

Orchik

Morff

Dunn

. Impedance audiometry in serous otitis media. Arch Otolaryngol 1978; 104: 409–12.

15.

Senturia

Bluestone

Klein

Lim

Paradise

. Report of the ad hoc committee on definition and classification of otitis media and otitis media with effusion. Ann Otol Rhinol Laryngol 1980; 89(suppl 68): 3–4.

16.

Schwartz

Stool

Rodriquez

Grundfast

. Acute otitis media: Toward a more precise definition. Clin Pediatr (Phila) 1981; 20: 549–54.

17.

Collier

HOJ

. Kinins and prostaglandins. Proc R Soc Med 1971; 64: 1–16.

18.

Willoughby

Giroud

DiRosa

Velo

. The control of inflammatory response with special reference to the prostaglandins. In: Kahn

Lands

WEM

, eds. Prostaglandins and cyclic AMP: Biological action and clinical applications. New York: Academic Press, 1973: 187–200.

19.

Jung

TTK

Smith

Juhn

Gerrard

. Prostaglandins and otitis media: Studies in the chinchilla. Otolaryngol Head Neck Surg 1980; 88: 316–23.

20.

Jung

TTK

Giebink

Juhn

. Effects of ibuprofen, corticosteroid and penicillin on the pathogenesis of experimental pneumococcal otitis media. In: Lim

Bluestone

Klein

Nelson

, eds. Recent advances in otitis media with effusion. Philadelphia: BC Decker, 1984: 269–72.

21.

Frady

Parker

Jackson

. Studies in permeability of the middle ear mucosa. The feasibility of blocking inflammatory mediators. Arch Otolaryngol 1977; 103: 47–51.

22.

Brown

Potsic

Marsh

Litt

. Drugs affecting clearance of middle ear secretions: A perspective for the management of otitis media with effusion. Ann Otol Rhinol Laryngol 1985; 94(suppl 117).